The Latest Prostate Treatment Research Breakthroughs
The Johns Hopkins Prostate Disorders Bulletin is the most comprehensive up-to-the-minute round-up of prostate care advances, new research findings, and clinical trials ever made available to medical consumers.
The Johns Hopkins Prostate Disorders Bulletin
The Johns Hopkins Prostate Disorders Bulletin works with doctors and professors of urology at one of the nation's foremost urological center, we are constantly impressed by the wealth of new therapies, important breakthroughs and newly-discovered preventive measures available to men at high risk for prostate problems, or undergoing treatment for them.
Yet for the average medical consumer, the information has simply been inaccessible -- hidden in obscure medical journals or buried in miniscule articles in the back of the daily newspaper. Even many physicians may not have ready access to up-to-the-minute research in this highly specialized field.
As the nation's leading center for prostate care and research, Johns Hopkins' James Buchanan Brady Urological Institute is in a unique position to evaluate and disseminate the very latest information concerning advances in prostate treatment. Now, Dr. Jacek Mostwin is leading a team of world-class prostate specialists as chief medical editor of a remarkable publication created for that precise purpose.
The Johns Hopkins Prostate Disorders Bulletin has one simple mission, one clear focus: to provide those facing prostate health challenges with the kind of authoritative, leading-edge information they need to take charge of their medical care -- intelligently and effectively.
The Johns Hopkins Prostate Disorders Bulletin brings you eye-opening reports about new therapeutic avenues... advance news of clinical trials in which you can participate... detailed answers to subscribers' most pressing questions and concerns... revealing research findings about nutrition, supplementation, lifestyle influences and diagnostic tools... and the latest news from urological and cancer conferences around the world. All with a single relentless focus on prostate issues and the preservation of your health and quality of life, and without mysterious medical jargon -- so you can clearly understand what the advances mean to you.
This can literally be life-changing information -- especially if you fall within the prostate high-risk target zone, which includes men over 40, African-Americans, and any male with a family history of prostate problems. In recent issues, The Prostate Disorders Bulletin subscribers have learned about:
- Why experts now estimate that up to 90 percent of cancers of the prostate may have a dietary link.
- New evidence that the progression of prostate cancer may actually be slowed by dietary changes. One study published in the Journal of Urology found that tumor cells from men taking flaxseed in combination with a lowfat diet appeared to be growing more slowly and dying more quickly than those of the control group.
- Two types of foods that should be included plentifully in the diet of anyone at risk for prostate problems -- or experiencing them.
- Important prostate issues to consider if you're contemplating testosterone replacement therapy. The good news: most urologists now recommend replacement therapy for men with low testosterone levels -- provided careful follow-up examinations are maintained.
- Must-read comparisons of the robotic-assisted and laparoscopic radical prostatectomy with the traditional radical prostatectomy. You'll get important insights about the relative merits of each approach for curing prostate cancer and maintaining quality of life.
- Why a new use of an oral hormonal medication may represent an important breakthrough in prostate cancer treatment.
- How a team of scientists and physicians is zeroing in on an improved Prostate Specific Antigen (PSA) test -- one which will reduce false positive readings and provide greater accuracy in predicting which men have PSA elevations due to benign prostate enlargement, and which are due to prostate cancer. The Prostate Disorders Bulletin readers will be kept apprised of their success as the data is reported.
- Five questions you should ask your surgeon if you are facing a radical prostatectomy. If he answers negatively to any one of them consider seeking treatment elsewhere. Question #1: does he know and use the nerve-sparing techniques in performing prostate surgery?
- Overactive bladder? You're not alone -- an estimated 17 million Americans, most under the age of 65, are affected by OAB. Your symptoms could be caused by one of the 12 trigger foods we reported on in our latest in-depth report on treating overactive bladder.
- The biggest mistake physicians make in prescribing drugs for prostate enlargement. Important reading for anyone taking Hytrin, Cardura, Flomax or Minipress.
- The pros and cons of medications, minimally-invasive therapies, and surgical alternatives in treating benign prostatic hyperplasia (BPH) -- the most common benign tumor found in men. Dr. Alan W. Partin, M.D., Ph.D, and Distinguished Professor of Urologic Oncology at the Johns Hopkins University School of Medicine reviews treatment options in our in-depth report on BPH.
- Where to find national listings of clinical trials of new therapies for BPH and prostate cancer -- and how you can apply to take part in them.
The most important publication you'll ever read --
yet your subscription is entirely risk-FREE.
If you or a loved one has reason to be concerned about prostate health, The Johns Hopkins Prostate Disorders Bulletin is the most essential resource you'll ever subscribe to -- even if you've never been diagnosed with a health-threatening prostate condition. The Prostate Disorders Bulletin will keep you abreast of the latest studies, therapies, and breakthroughs, alert you to clinical trials in which you can participate, and bring you the latest news from urological and cancer conferences around the world. All without medical jargon -- so you can clearly understand what the advances mean to you.
A risk-FREE opportunity
to improve your medical outlook --
and save $46!
This can literally be life-saving information... yet your subscription to The Prostate Disorders Bulletin is entirely risk-FREE. The subscription cost is just $149 for four quarterly issues... a savings of $46 off the regular subscription price. And, here's more good news: If you are dissatisfied with the Bulletin, for any reason... simply contact us within 30 days of receipt of your first issue for a prompt refund, no questions asked.
Your subscription will include:
- Four quarterly issues of The Prostate Disorders Bulletin, packed with up-to-the-minute health-essential information.
- Personal Letter reviewing critical prostate developments of the past few weeks. Each issue of The Prostate Disorders Bulletin starts with Dr. Mostwin's Personal Letter -- up to 20 pages of late-breaking news and information about the very latest treatment strategies and early intervention options, plus first-hand reports from urological conferences around the world that are helping men to prolong their lives, and improve their quality of life.
- In-Depth Reports on prostate health issues ranging from treatment options and preventive measures to prostatectomy techniques and new diagnostic tools. Each report is authored by a recognized expert on its topic -- including such medical authorities as H. Logan Holtgrewe, M.D., former president of the American Urological Association... Alan W. Partin, M.D., Ph.D., Urologist-in-Chief of the James Buchanan Brady Urological Institute and editor-in-chief of Urology... Patrick C. Walsh, M.D., former Director of the James Buchanan Brady Urological Institute... and literally dozens more who are at the forefront of prostate research and treatment.
- Participation in our Grand Rounds forum -- in which readers have the opportunity to pose specific prostate health questions to Johns Hopkins specialists. While we can't guarantee that every single question will be answered, typical issues include as many as ten to twelve pages' worth of readers' questions and expert answers.